Related Experiment Video
Updated: Jul 7, 2026
06:01
A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
Published on: August 18, 2015
15.4K
[Microangiopathies thrombotiques].
Léo Guénnoun1, Adrien Picod1, Paul Coppo2
1Centre de référence des microangiopathies thrombotiques, service d'hématologie, AP-HP et Sorbonne Université, Paris, France.
La Revue Du Praticien
|January 23, 2026
Summary
Thrombotic microangiopathies (TMAs) are serious conditions characterized by anemia, low platelets, and organ damage due to blood clots. Prompt diagnosis and specific therapies are crucial for improving patient outcomes in these complex hematologic disorders.
Area of Science:
- Hematology
- Internal Medicine
- Pathophysiology
Background:
- Thrombotic microangiopathy (TMA) is a life-threatening syndrome.
- It involves microvascular obstruction leading to organ failure.
- Key features include microangiopathic hemolytic anemia and thrombocytopenia.
Purpose of the Study:
- To review the main etiological entities of TMAs.
- To discuss their pathophysiology and clinical phenotypes.
- To highlight appropriate management, focusing on urgent and specific treatments.
Main Methods:
- Literature review of thrombotic microangiopathies.
- Analysis of etiological factors, pathophysiology, and clinical presentations.
- Evaluation of current and emerging therapeutic strategies.
Main Results:
- TMAs encompass thrombotic thrombocytopenic purpura (TTP) and atypical hemolytic uremic syndrome (aHUS).
- Other forms include post-infectious HUS and secondary TMAs related to various conditions.
- Specific therapies have significantly improved TMA prognosis.
Conclusions:
- Understanding TMA subtypes is essential for effective management.
- Timely and targeted therapies are critical for better patient outcomes.
- This review emphasizes the importance of prompt diagnosis and treatment for TMAs.
Keywords:
Thrombotic Microangiopathies
Related Concept Videos
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:30Venous Thrombosis I: Introduction
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:27Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
01:26Transient Ischemic Attack l: Introduction
A transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by a temporary, focal reduction in cerebral blood flow. Although symptoms resemble those of an ischemic stroke, the interruption in perfusion is short-lived and does not cause permanent infarction. TIAs are clinically important because they often serve as early warning events for future stroke.Mechanisms of Transient Cerebral IschemiaTransient cerebral ischemia may arise through several mechanisms. One...